Ex-smokers who relapse may simply be tired of the effort of not smoking
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-Dec-2025 03:11 ET (27-Dec-2025 08:11 GMT/UTC)
A research team led by Dr. Hyejeong Seong at the Brain Convergence Research Division of the Korea Institute of Science and Technology (KIST, President Sang-Rok Oh), in collaboration with Prof. Seongjun Park at Seoul National University (President Hong-Lim Ryu), announced the development of a breakthrough coating technology that extends the lifespan of implanted electrodes from 1 month to over 3 months.
July 10, 2025 - A research team led by Professor Yiwei Li and Professor Bi-Feng Liu from the College of Life Science and Technology at Huazhong University of Science and Technology (HUST) published an important research article titled "Mechanical Cell Reprogramming on Tissue-Mimicking Hydrogel for Cancer Cell Transdifferentiation" in the journal Research. The paper can be accessed through this link: https://spj.science.org/doi/10.34133/research.0810.
Professor Yiwei Li and Professor Bi-Feng Liu serve as corresponding authors, with doctoral students Xueqing Ren and Research Scientist Dr. Yachao Wang as co-first authors.
This study developed an innovative tissue-mimicking hydrogel system that achieves cell reprogramming through purely mechanical signals for the first time. The technology not only enhances the stemness and bidirectional differentiation potential of fibroblasts but also promotes cancer cell transdifferentiation into adipocytes, providing novel therapeutic strategies for regenerative medicine and cancer treatment.
New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by measuring cell-free DNA. The noninvasive test could not only allow neurologists to rule out other neurological diseases but also detect ALS disease earlier to provide better treatment and potentially improve life expectancy.
This review systematically delineates autophagy’s dual role in skin cancer: tumor-suppressive in early stages (via clearing dysfunctional cellular components to hinder malignant initiation) and tumor-promoting in advanced stages (sustaining cancer cell survival under stress). It characterizes natural, synthetic, and semisynthetic autophagy modulators (e.g., curcumin, rapamycin) that act through PI3K/Akt/mTOR or ROS pathways, with no notable adverse effects in preclinical models .
Its innovation lies in integrating subtype-specific autophagy regulatory mechanisms and modulator safety profiles. Clinically, it provides a framework for stage-specific strategies (inducers for early stages, inhibitors for advanced) and combination therapies, offering insights into personalized skin cancer treatment.